Daily Target 2X Short LLY ETF (LLYZ) Holdings
Esta página foi traduzida automaticamente do original em inglês por IA; a versão em inglês é a que prevalece. Ler a versão em inglês
Apenas para fins informativos. Não é um conselho financeiro.
Daily Target 2X Short LLY ETF (LLYZ) has a 1.29% expense ratio and $2M in assets under management. Holdings and weights below are as of Mar 15, 2026.
In the stored portfolio snapshot, the largest listed holding is First American Government Obligs X (FGXXX) at 21.44%.
Daily Target 2X Short LLY ETF (LLYZ) ETF — Price, Holdings & Analysis
Visão Geral do ETF
Métricas de Risco
- Beta: 0.00
Taxa de Despesa
O que o LLYZ detém?
| Posição | Peso |
|---|---|
| First American Government Obligs X (FGXXX) | 21.44% |
Estes dados do fundo têm mais de 45 dias; confirme as posições atuais com o emissor.
Como o fundo está alocado?
| País | Peso |
|---|---|
| Outros | 100.0% |
Dividend Yield
- iShares Morningstar Small-Cap Growth ETF (JKK) — 0.06% expense ratio
- ARK Innovation ETF (ARKK) — 0.75% expense ratio
- Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
- State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
- WisdomTree Emerging Markets ESG Fund (DVEM) — 0.32% expense ratio
- Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) — 0.59% expense ratio
- State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
- State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio
- Daily Target 2X Short PLTR ETF (PLTZ) (Equity) — 1.29% expense ratio
- Daily Target 2X Long OKLO ETF (OKLL) (Equity) — 1.31% expense ratio
- Daily Target 2X Long RKLB ETF (RKLX) (Equity) — 1.31% expense ratio
- Daily Target 2X Long SOFI ETF (SOFX) (Equity) — 1.29% expense ratio
- S&P 500 Weekly Distribution ETF (WDTE) (Equity) — 1.03% expense ratio
- Defiance BMNR Option Income ETF (YBMN) (Equity) — 0.85% expense ratio
Perguntas e Respostas
What is LLYZ and what does it track?
The Daily Target 2X Short LLY ETF (LLYZ) is an ETF offered by Defiance that aims to provide daily investment results, before fees and expenses, corresponding to two times the inverse (-200%) of the daily percentage change in the share…
price of Eli Lilly and Company.
What is the expense ratio for LLYZ?
The expense ratio for LLYZ is 1.29%. This means that for every $10,000 invested in the fund, $129 is deducted annually to cover the fund's operating expenses.
This expense ratio is significantly higher than the average expense ratio for equity ETFs, which is around 0.44%. The higher expense ratio reflects the complexities and costs associated with managing a leveraged and inverse ETF.
What are the top holdings in LLYZ?
As of 2026-03-15, the top holding in LLYZ is First American Government Obligs X (FGXXX), comprising 21.44% of the fund's assets. The fund holds 7 assets in total. The significant allocation to FGXXX suggests a strategy of using short-term U.S.
government obligations to manage the fund's leveraged exposure and meet its daily investment objective. Investors should review the complete holdings list periodically for any changes.
Is LLYZ a good long-term investment?
LLYZ is generally not considered suitable for long-term investment. Its investment objective is to provide twice the inverse of the daily percentage change in the share price of Eli Lilly and Company.
Due to the effects of compounding, the fund's performance over periods longer than a single day can deviate significantly from its stated daily objective.
How does LLYZ compare to similar ETFs?
LLYZ is unique in its focus on providing leveraged inverse exposure specifically to the daily performance of Eli Lilly and Company. While there are other leveraged and inverse ETFs available, most track broader market indices or sectors.
LLYZ's expense ratio of 1.29% is higher than many non-leveraged ETFs.
Does LLYZ pay dividends?
According to the available data, LLYZ has a dividend yield of 0.00%. This indicates that the fund does not currently distribute any dividends to its shareholders.
The fund's primary objective is to provide leveraged inverse exposure to the daily price movements of Eli Lilly, rather than generating income through dividends. Investors seeking dividend income should consider alternative investment options.
Aviso Legal: Este conteúdo tem fins informativos apenas e não constitui aconselhamento de investimento. Sempre faça sua própria pesquisa e consulte um consultor financeiro.
Dados fornecidos apenas para fins informativos.
Escrito por uma máquina, sem revisão página a página. A supervisão editorial é sistémica: verificam-se as regras e as fontes, não cada página.